PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Thermo Fisher Scientific Introduces High Content 2.0 at Cambridge Healthtech Meeting - Thermo Fisher Scientific Inc., introduced Thermo Scientific High Content 2.0, an evolution of automated, quantitative cell imaging for life scientists studying cell function in oncology, neurobiology, toxicology and systems biology
Thermo Fisher Scientific Introduces High Content 2.0 at Cambridge Healthtech Meeting

 

NewswireToday - /newswire/ - Pittsburgh, PA, United States, 2010/01/12 - Thermo Fisher Scientific Inc., introduced Thermo Scientific High Content 2.0, an evolution of automated, quantitative cell imaging for life scientists studying cell function in oncology, neurobiology, toxicology and systems biology.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced Thermo Scientific High Content 2.0, an evolution of automated, quantitative cell imaging for life scientists studying cell function in oncology, neurobiology, toxicology and systems biology. High Content 2.0 builds on the success of high content screening (HCS) and high content analysis, advancing the Thermo Scientific Cellomics ArrayScan® VTI, the most productive HCS platform in the industry that leverages years of customer input. High Content 2.0 offers unparalleled ease-of-use, performance and reproducibility through unique improvements in hardware and software. High Content 2.0 will be exclusively demonstrated within booth #11 at the Cambridge Healthtech Institute High Content Analysis Meeting, held in San Francisco from January 11-15 2010.

New iDEV™ guided workflow software is just one of the innovative additions to the High Content 2.0 platform. The software is designed for the rigors of multi-user environments and provides even the occasional user with the means to efficiently and effectively develop cell imaging assays. Leveraging Thermo Fisher Scientific’s best-in-class image analysis tools, iDEV combines a more intuitive, step-by-step assay setup with an industry first “easy assay optimizer” feature that addresses multiple groups of biological states simultaneously to dramatically reduce critical assay development timelines. This unique, interactive tool allows the user to simultaneously visualize algorithmic parameter changes at the image, data and statistical level in real time.

An innovative LED light engine, designed to overcome the limitations of current bulb technology, offers unprecedented speed and reliability for screening campaigns while reducing exposure times, data variability and consumable expenses. With an extremely stable ”solid state” five-color light excitation capability, more than 10,000 hour life and low power consumption, the LED light engine offers significant improvements in large-scale data generation with a dramatically reduced environmental footprint.

High Content 2.0 also incorporates the latest optical bench from Carl Zeiss, the AxioVert® Z1, which adds more than 160 years of optical expertise to improve optics and automation. With a performance benchmark of fewer than four minutes to image and analyze a typical two channel 96 well plate, the ArrayScan VTI is the fastest high content reader in its class. For the demanding researcher, the Z1 optical bench offers the confidence of a proven optical train, compared to custom optical trains, and allows for future developments as Carl Zeiss delivers new innovation.

For more information about the Thermo Scientific range of products for high content imaging, please visit booth #11 at the Cambridge Healthtech Institute High Content Analysis Meeting. Alternatively, please call 1-800-432-4091

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With 2008 revenues of $10.5 billion, we have approximately 34,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Thermo Fisher Scientific Introduces High Content 2.0 at Cambridge Healthtech Meeting

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Eleanor Thouret 
+44 1477 539539
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Frost & Sullivan Honors Linguamatics for Developing a Best-in-Class NLP-based Data Mining Platform for the Healthcare Industry
Therapist Launches Podcast to Reach Larger Audience
Top Innovative Health and Wellness Technologies to Accelerate Global Adoption of Precision Medicine Finds Frost & Sullivan
Rheumatoid Arthritis Diagnosis Tests Market Size to Expand At 6.2% CAGR through 2022 Says PMR
Persistence Market Research Publishes Health Information Exchange Market Opportunities and Forecasts 2017-2025
Persistence Market Research Publishes Microtome Cryostat Equipment Market Opportunities and Forecasts, 2017-2025
North America to Account for 4.3% CAGR in Global Hip Replacement Market Reports Persistence Market Research
HPMC Capsules Market to Register 10.9% CAGR During 2017-2025 Finds Persistence Market Research
Persistence Market Research Publishes Blood Thinner Market Opportunities and Forecasts 2017-2025
Occupational Medicine Market Estimated to Expand At A Robust CAGR Over 2025 Notes PMR
Persistence Market Research Publishes Traditional Chinese Medicine Market Forecast Over 2017-2025
Inferior Vena Cava Filters Market to Register A Strong Growth by 2025 Notes Persistence Market Research
Plasma Component Separator Market Set to Surge Significantly During 2017-2025 Says PMR
Persistence Market Research Releases Fertility Enhancing Treatment Market Snapshot by 2017-2025
Disposable Diabetes Devices Market Expected to Generate Huge Profits by 2025 Finds Reports Persistence Market Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Rapid Recovery

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)